Portfolio (Quarterly)
Guide ↗
Medicxi Ventures Management (Jersey) Ltd
· CIK 0001715579| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 19,963,157.0 | $484.1M | 65.03% | NEW | — | $24.25 | +63.5% |
| 2 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 7,464,572.0 | $87.9M | 11.80% | NEW | — | $11.77 | +0.8% |
| 3 | — | NEWAMSTERDAM PHARMA COMPANY | — | 2,869,565.0 | $81.6M | 10.96% | NEW | — | $28.44 | — |
| 4 | — | RAPT THERAPEUTICS INC | — | 2,794,000.0 | $72.1M | 9.68% | NEW | — | $25.79 | — |
| 5 | AURA | AURA BIOSCIENCES INC | Healthcare | 3,039,892.0 | $18.8M | 2.52% | NEW | — | $6.18 | +20.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%